Global Digital Therapeutics (DTx) For Mental Health Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 05 Sep 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Digital Therapeutics (DTx) For Mental Health market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Digital Therapeutics (DTx) For Mental Health industry chain, the market status of Pharmaceutical Companies (Biology Modifying Drugs, Gene Therapies), Academic and Research Institutions (Biology Modifying Drugs, Gene Therapies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Digital Therapeutics (DTx) For Mental Health.

Regionally, the report analyzes the Digital Therapeutics (DTx) For Mental Health markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Digital Therapeutics (DTx) For Mental Health market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Digital Therapeutics (DTx) For Mental Health market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Digital Therapeutics (DTx) For Mental Health industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biology Modifying Drugs, Gene Therapies).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Digital Therapeutics (DTx) For Mental Health market.

Regional Analysis: The report involves examining the Digital Therapeutics (DTx) For Mental Health market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Digital Therapeutics (DTx) For Mental Health market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Digital Therapeutics (DTx) For Mental Health:
Company Analysis: Report covers individual Digital Therapeutics (DTx) For Mental Health players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Digital Therapeutics (DTx) For Mental Health This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Academic and Research Institutions).

Technology Analysis: Report covers specific technologies relevant to Digital Therapeutics (DTx) For Mental Health. It assesses the current state, advancements, and potential future developments in Digital Therapeutics (DTx) For Mental Health areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Digital Therapeutics (DTx) For Mental Health market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Digital Therapeutics (DTx) For Mental Health market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Biology Modifying Drugs
    Gene Therapies
    Cell Therapies

Market segment by Application
    Pharmaceutical Companies
    Academic and Research Institutions
    Others

Market segment by players, this report covers
    Noom
    Teladoc Health
    Omada Health
    WellDoc
    Pear Therapeutics
    COGNIFIT
    Ginger
    Propeller Health
    2morrow
    Canary Health

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Therapeutics (DTx) For Mental Health product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Therapeutics (DTx) For Mental Health, with revenue, gross margin and global market share of Digital Therapeutics (DTx) For Mental Health from 2018 to 2023.
Chapter 3, the Digital Therapeutics (DTx) For Mental Health competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Digital Therapeutics (DTx) For Mental Health market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Therapeutics (DTx) For Mental Health.
Chapter 13, to describe Digital Therapeutics (DTx) For Mental Health research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Digital Therapeutics (DTx) For Mental Health
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Digital Therapeutics (DTx) For Mental Health by Type
        1.3.1 Overview: Global Digital Therapeutics (DTx) For Mental Health Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type in 2022
        1.3.3 Biology Modifying Drugs
        1.3.4 Gene Therapies
        1.3.5 Cell Therapies
    1.4 Global Digital Therapeutics (DTx) For Mental Health Market by Application
        1.4.1 Overview: Global Digital Therapeutics (DTx) For Mental Health Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical Companies
        1.4.3 Academic and Research Institutions
        1.4.4 Others
    1.5 Global Digital Therapeutics (DTx) For Mental Health Market Size & Forecast
    1.6 Global Digital Therapeutics (DTx) For Mental Health Market Size and Forecast by Region
        1.6.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region, (2018-2029)
        1.6.3 North America Digital Therapeutics (DTx) For Mental Health Market Size and Prospect (2018-2029)
        1.6.4 Europe Digital Therapeutics (DTx) For Mental Health Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size and Prospect (2018-2029)
        1.6.6 South America Digital Therapeutics (DTx) For Mental Health Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Digital Therapeutics (DTx) For Mental Health Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Noom
        2.1.1 Noom Details
        2.1.2 Noom Major Business
        2.1.3 Noom Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.1.4 Noom Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Noom Recent Developments and Future Plans
    2.2 Teladoc Health
        2.2.1 Teladoc Health Details
        2.2.2 Teladoc Health Major Business
        2.2.3 Teladoc Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.2.4 Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Teladoc Health Recent Developments and Future Plans
    2.3 Omada Health
        2.3.1 Omada Health Details
        2.3.2 Omada Health Major Business
        2.3.3 Omada Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.3.4 Omada Health Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Omada Health Recent Developments and Future Plans
    2.4 WellDoc
        2.4.1 WellDoc Details
        2.4.2 WellDoc Major Business
        2.4.3 WellDoc Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.4.4 WellDoc Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 WellDoc Recent Developments and Future Plans
    2.5 Pear Therapeutics
        2.5.1 Pear Therapeutics Details
        2.5.2 Pear Therapeutics Major Business
        2.5.3 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.5.4 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Pear Therapeutics Recent Developments and Future Plans
    2.6 COGNIFIT
        2.6.1 COGNIFIT Details
        2.6.2 COGNIFIT Major Business
        2.6.3 COGNIFIT Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.6.4 COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 COGNIFIT Recent Developments and Future Plans
    2.7 Ginger
        2.7.1 Ginger Details
        2.7.2 Ginger Major Business
        2.7.3 Ginger Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.7.4 Ginger Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Ginger Recent Developments and Future Plans
    2.8 Propeller Health
        2.8.1 Propeller Health Details
        2.8.2 Propeller Health Major Business
        2.8.3 Propeller Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.8.4 Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Propeller Health Recent Developments and Future Plans
    2.9 2morrow
        2.9.1 2morrow Details
        2.9.2 2morrow Major Business
        2.9.3 2morrow Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.9.4 2morrow Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 2morrow Recent Developments and Future Plans
    2.10 Canary Health
        2.10.1 Canary Health Details
        2.10.2 Canary Health Major Business
        2.10.3 Canary Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
        2.10.4 Canary Health Digital Therapeutics (DTx) For Mental Health Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Canary Health Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Digital Therapeutics (DTx) For Mental Health Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Digital Therapeutics (DTx) For Mental Health by Company Revenue
        3.2.2 Top 3 Digital Therapeutics (DTx) For Mental Health Players Market Share in 2022
        3.2.3 Top 6 Digital Therapeutics (DTx) For Mental Health Players Market Share in 2022
    3.3 Digital Therapeutics (DTx) For Mental Health Market: Overall Company Footprint Analysis
        3.3.1 Digital Therapeutics (DTx) For Mental Health Market: Region Footprint
        3.3.2 Digital Therapeutics (DTx) For Mental Health Market: Company Product Type Footprint
        3.3.3 Digital Therapeutics (DTx) For Mental Health Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Digital Therapeutics (DTx) For Mental Health Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Digital Therapeutics (DTx) For Mental Health Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2023)
    5.2 Global Digital Therapeutics (DTx) For Mental Health Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2029)
    6.2 North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2029)
    6.3 North America Digital Therapeutics (DTx) For Mental Health Market Size by Country
        6.3.1 North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2029)
        6.3.2 United States Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        6.3.3 Canada Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        6.3.4 Mexico Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2029)
    7.2 Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2029)
    7.3 Europe Digital Therapeutics (DTx) For Mental Health Market Size by Country
        7.3.1 Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2029)
        7.3.2 Germany Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        7.3.3 France Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        7.3.5 Russia Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        7.3.6 Italy Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size by Region
        8.3.1 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Region (2018-2029)
        8.3.2 China Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        8.3.3 Japan Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        8.3.4 South Korea Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        8.3.5 India Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        8.3.7 Australia Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2029)
    9.2 South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2029)
    9.3 South America Digital Therapeutics (DTx) For Mental Health Market Size by Country
        9.3.1 South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2029)
        9.3.2 Brazil Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        9.3.3 Argentina Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size by Country
        10.3.1 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2029)
        10.3.2 Turkey Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)
        10.3.4 UAE Digital Therapeutics (DTx) For Mental Health Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Digital Therapeutics (DTx) For Mental Health Market Drivers
    11.2 Digital Therapeutics (DTx) For Mental Health Market Restraints
    11.3 Digital Therapeutics (DTx) For Mental Health Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Digital Therapeutics (DTx) For Mental Health Industry Chain
    12.2 Digital Therapeutics (DTx) For Mental Health Upstream Analysis
    12.3 Digital Therapeutics (DTx) For Mental Health Midstream Analysis
    12.4 Digital Therapeutics (DTx) For Mental Health Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Noom Company Information, Head Office, and Major Competitors
    Table 6. Noom Major Business
    Table 7. Noom Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 8. Noom Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Noom Recent Developments and Future Plans
    Table 10. Teladoc Health Company Information, Head Office, and Major Competitors
    Table 11. Teladoc Health Major Business
    Table 12. Teladoc Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 13. Teladoc Health Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Teladoc Health Recent Developments and Future Plans
    Table 15. Omada Health Company Information, Head Office, and Major Competitors
    Table 16. Omada Health Major Business
    Table 17. Omada Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 18. Omada Health Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Omada Health Recent Developments and Future Plans
    Table 20. WellDoc Company Information, Head Office, and Major Competitors
    Table 21. WellDoc Major Business
    Table 22. WellDoc Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 23. WellDoc Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. WellDoc Recent Developments and Future Plans
    Table 25. Pear Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. Pear Therapeutics Major Business
    Table 27. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 28. Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Pear Therapeutics Recent Developments and Future Plans
    Table 30. COGNIFIT Company Information, Head Office, and Major Competitors
    Table 31. COGNIFIT Major Business
    Table 32. COGNIFIT Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 33. COGNIFIT Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. COGNIFIT Recent Developments and Future Plans
    Table 35. Ginger Company Information, Head Office, and Major Competitors
    Table 36. Ginger Major Business
    Table 37. Ginger Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 38. Ginger Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Ginger Recent Developments and Future Plans
    Table 40. Propeller Health Company Information, Head Office, and Major Competitors
    Table 41. Propeller Health Major Business
    Table 42. Propeller Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 43. Propeller Health Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Propeller Health Recent Developments and Future Plans
    Table 45. 2morrow Company Information, Head Office, and Major Competitors
    Table 46. 2morrow Major Business
    Table 47. 2morrow Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 48. 2morrow Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. 2morrow Recent Developments and Future Plans
    Table 50. Canary Health Company Information, Head Office, and Major Competitors
    Table 51. Canary Health Major Business
    Table 52. Canary Health Digital Therapeutics (DTx) For Mental Health Product and Solutions
    Table 53. Canary Health Digital Therapeutics (DTx) For Mental Health Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Canary Health Recent Developments and Future Plans
    Table 55. Global Digital Therapeutics (DTx) For Mental Health Revenue (USD Million) by Players (2018-2023)
    Table 56. Global Digital Therapeutics (DTx) For Mental Health Revenue Share by Players (2018-2023)
    Table 57. Breakdown of Digital Therapeutics (DTx) For Mental Health by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Digital Therapeutics (DTx) For Mental Health, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key Digital Therapeutics (DTx) For Mental Health Players
    Table 60. Digital Therapeutics (DTx) For Mental Health Market: Company Product Type Footprint
    Table 61. Digital Therapeutics (DTx) For Mental Health Market: Company Product Application Footprint
    Table 62. Digital Therapeutics (DTx) For Mental Health New Market Entrants and Barriers to Market Entry
    Table 63. Digital Therapeutics (DTx) For Mental Health Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Digital Therapeutics (DTx) For Mental Health Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Share by Type (2018-2023)
    Table 66. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Forecast by Type (2024-2029)
    Table 67. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023)
    Table 68. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Forecast by Application (2024-2029)
    Table 69. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa Digital Therapeutics (DTx) For Mental Health Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. Digital Therapeutics (DTx) For Mental Health Raw Material
    Table 100. Key Suppliers of Digital Therapeutics (DTx) For Mental Health Raw Materials
List of Figures
    Figure 1. Digital Therapeutics (DTx) For Mental Health Picture
    Figure 2. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type in 2022
    Figure 4. Biology Modifying Drugs
    Figure 5. Gene Therapies
    Figure 6. Cell Therapies
    Figure 7. Global Digital Therapeutics (DTx) For Mental Health Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application in 2022
    Figure 9. Pharmaceutical Companies Picture
    Figure 10. Academic and Research Institutions Picture
    Figure 11. Others Picture
    Figure 12. Global Digital Therapeutics (DTx) For Mental Health Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Digital Therapeutics (DTx) For Mental Health Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Market Digital Therapeutics (DTx) For Mental Health Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 15. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Region (2018-2029)
    Figure 16. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Region in 2022
    Figure 17. North America Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 18. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 19. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 20. South America Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 21. Middle East and Africa Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 22. Global Digital Therapeutics (DTx) For Mental Health Revenue Share by Players in 2022
    Figure 23. Digital Therapeutics (DTx) For Mental Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 24. Global Top 3 Players Digital Therapeutics (DTx) For Mental Health Market Share in 2022
    Figure 25. Global Top 6 Players Digital Therapeutics (DTx) For Mental Health Market Share in 2022
    Figure 26. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Share by Type (2018-2023)
    Figure 27. Global Digital Therapeutics (DTx) For Mental Health Market Share Forecast by Type (2024-2029)
    Figure 28. Global Digital Therapeutics (DTx) For Mental Health Consumption Value Share by Application (2018-2023)
    Figure 29. Global Digital Therapeutics (DTx) For Mental Health Market Share Forecast by Application (2024-2029)
    Figure 30. North America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type (2018-2029)
    Figure 31. North America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2029)
    Figure 32. North America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Country (2018-2029)
    Figure 33. United States Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 34. Canada Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 35. Mexico Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 36. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type (2018-2029)
    Figure 37. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2029)
    Figure 38. Europe Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Country (2018-2029)
    Figure 39. Germany Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 40. France Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 41. United Kingdom Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 42. Russia Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 43. Italy Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 44. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type (2018-2029)
    Figure 45. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2029)
    Figure 46. Asia-Pacific Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Region (2018-2029)
    Figure 47. China Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 48. Japan Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 49. South Korea Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 50. India Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 51. Southeast Asia Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 52. Australia Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 53. South America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type (2018-2029)
    Figure 54. South America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2029)
    Figure 55. South America Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Country (2018-2029)
    Figure 56. Brazil Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 57. Argentina Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 58. Middle East and Africa Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Type (2018-2029)
    Figure 59. Middle East and Africa Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Application (2018-2029)
    Figure 60. Middle East and Africa Digital Therapeutics (DTx) For Mental Health Consumption Value Market Share by Country (2018-2029)
    Figure 61. Turkey Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 62. Saudi Arabia Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 63. UAE Digital Therapeutics (DTx) For Mental Health Consumption Value (2018-2029) & (USD Million)
    Figure 64. Digital Therapeutics (DTx) For Mental Health Market Drivers
    Figure 65. Digital Therapeutics (DTx) For Mental Health Market Restraints
    Figure 66. Digital Therapeutics (DTx) For Mental Health Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Digital Therapeutics (DTx) For Mental Health in 2022
    Figure 69. Manufacturing Process Analysis of Digital Therapeutics (DTx) For Mental Health
    Figure 70. Digital Therapeutics (DTx) For Mental Health Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Noom
Teladoc Health
Omada Health
WellDoc
Pear Therapeutics
COGNIFIT
Ginger
Propeller Health
2morrow
Canary Health

Related Reports

Global Digital Therapeutics (DTx) For Mental Health Supply, Demand and Key Producers, 2023-2029

Global Digital Therapeutics (DTx) For Mental Health Supply, Demand and Key Producers, 2023-2029

date 05 Sep 2023

date Service & Software

The global Digital Therapeutics (DTx) For Mental Health market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Digital Therapeutics (DTx) For Mental Health Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Digital Therapeutics (DTx) For Mental Health Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Digital Therapeutics (DTx) For Mental Health market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Digital Therapeutics (DTx) For Mental Health Supply, Demand and Key Producers, 2024-2030

Global Digital Therapeutics (DTx) For Mental Health Supply, Demand and Key Producers, 2024-2030

date 05 Mar 2024

date Service & Software

The global Digital Therapeutics (DTx) For Mental Health market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Digital Therapeutics (DTx) For Mental Health

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>